A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS3797 in Healthy Subjects
Clinical trial NCT05701826 · COMPLETED
Trial details
- NCT number
- NCT05701826
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2023-06-02
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.